Nuix Limited (NXL) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the newest limited first half 26 results conference call. All participants are in a listen-only mode. It will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypads. I would now like to hand the conference call over to Mr. John Riven, CEO. Please go ahead. Welcome everyone and thank you for joining us for Neurex's half-year 2026 results presentation. I'm John Riven, Neurex's interim CEO and with me today is our Chief Financial Officer, Peter McClelland. I'll begin today with our key messages and metrics for the half, then discuss Neurex, NEO and our strategic positioning in the AI era. Peter will then walk through our financial results in detail. After that I'll provide our outlook before taking questions. Let me start with the highlights from the half. We've delivered ACV growth of 8.4% to $234.4 million. NEO performance has been strong. ACV grew 148% on PCP to reach $46.8 million, now representing 20% of our ACV. Revenue grew 15.2% to $121.2 million, driving adjusted management EBITDA to $19.1 million, up 42.6%, demonstrating significant operating leverage. We've achieved a material lift in cash generation with positive underlying and overall cash flow, finishing with a closing cash balance of $57.8 million. We've launched a comprehensive Neuris Neo migration program, to systematically transition our customer base to the modern platform and drive ACV growth. We'll spend some time shortly talking about how NUIX Neo plus AI creates amplified capabilities, incorporating our BYO AI framework. This powerful combination of large-scale forensic data analysis and LLM integration flexibility creates a structur...